The GLP-1 Capacity Squeeze
September 16, 2026
As demand for GLP-1 medicines grows, injectable manufacturers must increase output without compromising quality or squeezing supply for other therapies
4 min read
False
Advertisement
Top Stories
Browse By Topic
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
Voices in the Community
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
Bruce Levine
Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine
View ProfileMusings from The Power List: Claudia Zylberberg
Claudia Zylberberg discusses building the infrastructure, partnerships, and policies needed to bring advanced therapies to patients at scale
Latest News
All the latest Medicine Maker articles.
Biomarker Could Predict Response to Low-Dose CAR T Cell Therapy
September 14, 2026
CD27-negative, CD39-negative CAR T cells were associated with treatment response when limited cell numbers were administered
3 min read
What Do Scientists Want from AI?
September 14, 2026
Scientists are already using AI in the lab – but many are doing so without the safeguards their employers may assume are in place
5 min read
Roving Reporter Asks: How Should We Redefine Value, Access, and Affordability in Cell and Gene Therapy?
September 11, 2026
IBTV speaks with industry leaders at ASGCT 2026 about new approaches to manufacturing, reimbursement, treatment delivery, and long-term value that could bring cell and gene therapies to more patients
1 min read
Musings from The Power List: Ali Tavassoli
September 10, 2026
Ali Tavassoli explains how cyclic peptides and new discovery tools are opening up once-inaccessible biology
8 min read
The Manufacturing Questions Facing Chinese Biotech
September 9, 2026
Lonza’s Wayne Wen discusses the growing maturity of China’s drug development and manufacturing ecosystem – and what companies need to compete internationally
5 min read
Musings from The Power List: Miguel Forte
September 8, 2026
Scientific progress alone isn't enough, says Miguel Forte, who argues that reimbursement and patient access will shape the next decade of cell and gene therapy
4 min read
CD19 CAR T Therapy Tested in Refractory Rheumatoid Arthritis
September 8, 2026
Disease activity fell in all six participants in a phase I trial, with three achieving sustained drug-free remission during follow-up
2 min read
Manufacturing Reality Behind Personalized Cancer Vaccines
September 7, 2026
As personalized cancer vaccines move closer to commercialization, manufacturers must rethink DNA production to deliver batch-for-one treatments with the required speed, consistency, and quality
3 min read
CAR T Before Surgery Improves Glioblastoma Control in Mice
September 7, 2026
Study finds that tumor resection creates a more immunosuppressive environment and that earlier CAR T cell treatment prolongs survival
2 min read
Musings from The Power List: Peng Lu
September 4, 2026
Peng Lu argues that small molecules remain indispensable as AI transforms drug development
2 min read
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.